Skip to main content
. 2022 Apr 11;40:101019. doi: 10.1016/j.ijcha.2022.101019

Table 1.

Baseline demographics, comorbidities and study characteristics of studies included in the meta-analysis.

Variable Ng et al, 2013[3] Dror et al, 2013[18] Verdoia et al., 2021[1] Khalili et al., 2012[19] Khademvatani et al., 2017[20] Madhavi et al., 2013[21] Walker et al., 2014[23] Schiller et al., 2015[22]
Sample (n)
Hypovitaminosis D/ Control
945/314 240892/181930 485/220 101/38 142/28 192/24 71/57 34/58
Age, y(Mean) 65.5/66.2 NA 67.2/67.5 59.6/63.1 57.71/68.1 65.7/60.89 64.4/69.7 NA
Male, % 70.3/77.3 28.7/34.1 78.3/75.4 84.1/
77.1
71.8/57.1 40.1/45.8 95.8/98.2 NA
BMI, kg/m2 (mean) NA NA 27.8/26.2 NA NA 25.71/25.36 NA 26.4/26.37
Comorbidities
HTN, % 52.4/42.6 14.5/12 75.5/72.7 60.3/36.8 49.3/50 66.1/58.3 95.8/100 NA
HLD, % NA NA 61.6/59 40.6/42.1 NA 44.8/50 67.6/80.7 NA
DM, % 26.4/13.7 49/42 43.7/31.8 25.7/31.6 80.2/89.2 66.7/50 59.1/63.1 100/100
Smoker, % 43.8/45.9 25.8/26 55.2/51.4 NA 50/42.9 34.8/12.5 21.2/15.8 NA
Previous PCI, % NA NA 59.1/60 28.7/21 NA NA NA NA
Previous MI, % 24.2/13.4 4.7/5.1 24.5/19.5 NA 10.6/17.9 NA 47.9/52.6 NA
Previous Stroke, % NA NA NA NA NA NA 21.1/7 NA

HTN – Hypertension; HLD – Hyperlipidemia; DM – Diabetes Mellitus (type 2); PCI – Percutaneous Coronary Intervention; MI – Myocardial Infarction.